Screener
Design Therapeutics, Inc. DSGN Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Design Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026.
- Filed
- Apr 28, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-187063
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total assets | $230,442 | $226,203 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $2,276 | $2,312 |
| Accrued expenses and other current liabilities (including related party amounts of $890 as of December 31, 2025) | 7,914 | 10,743 |
| Total current liabilities | 10,190 | 13,055 |
| Operating lease liability | 2,198 | 645 |
| Total liabilities | 12,388 | 13,700 |
Item 1. Financial Statements.
FAQ
- What is Design Therapeutics, Inc.'s accounts payable?
- Design Therapeutics, Inc. (DSGN) reported accounts payable of $2.28M in Q1 2026.
- How has Design Therapeutics, Inc.'s accounts payable changed year-over-year?
- Design Therapeutics, Inc.'s accounts payable decreased by 28.4% year-over-year, from $3.18M to $2.28M.
- What is the long-term trend for Design Therapeutics, Inc.'s accounts payable?
- Over 5 years (2020 to 2025), Design Therapeutics, Inc.'s accounts payable has grown at a 10.6% compound annual growth rate (CAGR), from $1.4M to $2.31M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about Design Therapeutics, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude